Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software will be presented at the upcoming American Society of Echocardiography (ASE) 30th Annual Scientific Sessions, June 21-25 in Portland, Ore.

DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's LVivo EF artificial intelligence (AI)-based solution that generates fully automated left ventricular ejection fraction (LVEF). EF is a main indicator in assessing the global function of the left ventricle. Presently, many readers quantify EF visually or trace endocardial borders that may not be well defined, yielding high variability among results. LVivo EF aims to substantially reduce this variability by generating objective, accurate and fast AI-based EF.

Washington Open MRI (WOMRI) has selected RamSoft’s PowerServer RIS/PACS (radiology information system/picture archiving and communication system) to unify its diagnostic imaging workflow into a single database solution in its six facilities across the state of Maryland.

GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy in patients with previously irradiated intracranial neoplasms (brain tumors) at the American Brachytherapy Society (ABS) 2019 Annual Meeting, June 13-15 in Miami. These data reinforce the safety profile of GammaTile Therapy, a surgically targeted radiation therapy (STaRT) that is designed to delay tumor regrowth for patients with recurrent intracranial neoplasms (brain tumors).

A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their prostate cancer. The findings come at a time when a growing number of men with prostate cancer considered “low risk” are opting for active surveillance or watchful waiting rather than immediate treatment with surgery or radiation.

An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for imaging techniques to help diagnose multiple myeloma and other plasma-cell disorders.

Sectra has signed a five-year contract with North Tees and Hartlepool National Health System (NHS) Foundation Trust for the delivery of a regional digital pathology solution to the Northern Cancer Alliance in the U.K. The solution will span the 10 separate trusts of the consortium, and aims to improve cancer care workflows through enabling pathologists to instantly access and share images and information between departments and locations.

IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and clinically implemented a novel automated treatment log-based patient quality assurance (QA) approach for proton therapy. This enables them to reduce the time needed for the in-beam measurement-based conventional patient QA.

M*Modal announced that the company and Community Health Network (CHNw) are collaborating to transform the patient-physician experience while improving provider and clinician satisfaction and care quality.